Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. [electronic resource]
Producer: 20190227Description: 720-728 p. digitalISSN:- 1533-4406
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Double-Blind Method
- Factor Xa Inhibitors -- adverse effects
- Female
- Hemorrhage -- chemically induced
- Humans
- Incidence
- Intention to Treat Analysis
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasms -- complications
- Risk Factors
- Rivaroxaban -- adverse effects
- Treatment Outcome
- Venous Thromboembolism -- etiology
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.